Literature DB >> 30629990

Relaxin and the 'Milky Way': The lactocrine hypothesis and maternal programming of development.

Carol A Bagnell1, Frank F Bartol2.   

Abstract

Maternal effects on early postnatal development in mammals are mediated, in part, by milk-borne bioactive factors transmitted from mother to nursing offspring. The term 'lactocrine' was coined to describe this mode of signaling. Relaxin (RLX), one of a family of neohormones found in mammals, is detectable in milk from multiple species. In the pig, evidence of bioactive proRLX in colostrum/milk, immunoreactive RLX in the circulation of nursed neonates, and RLX receptor expression in RLX-sensitive neonatal female reproductive tract tissues, established RLX as a prototypical lactocrine-active factor. Observations provided the foundation for the lactocrine hypothesis for maternal programming of postnatal development. Studies designed to test the lactocrine hypothesis provided insights into both short-term effects of milk-borne bioactive factors in the neonate, and long-term consequences of maternal lactocrine programming of endometrial function and fecundity in adults. Thus, RLX led to the 'Milky Way'.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Development; Neonate; Nursing; Pig; Relaxin; Uterus

Mesh:

Substances:

Year:  2019        PMID: 30629990     DOI: 10.1016/j.mce.2019.01.003

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  2 in total

Review 1.  Uterine Glands: Developmental Biology and Functional Roles in Pregnancy.

Authors:  Andrew M Kelleher; Francesco J DeMayo; Thomas E Spencer
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

2.  Increasing serotonin bioavailability alters gene expression in peripheral leukocytes and lymphoid tissues of dairy calves.

Authors:  M G Marrero; S L Field; A L Skibiel; B Dado-Senn; J P Driver; J Laporta
Journal:  Sci Rep       Date:  2020-06-16       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.